Zobrazeno 1 - 10
of 63
pro vyhledávání: '"C G, Brook"'
Autor:
C G, Brook, B B, de Vries
Publikováno v:
Archives of Disease in Childhood. 79:285-289
Autor:
C G, Brook
Publikováno v:
Hormone research. 54(3)
Autor:
A J, Swerdlow, R E, Reddingius, C D, Higgins, H A, Spoudeas, K, Phipps, Z, Qiao, W D, Ryder, M, Brada, R D, Hayward, C G, Brook, P C, Hindmarsh, S M, Shalet
Publikováno v:
The Journal of clinical endocrinology and metabolism. 85(12)
GH is increasingly used for treatment of children and adults. It is mitogenic, however, and there is therefore concern about its safety, especially when used to treat cancer patients who have become GH deficient after cranial radiotherapy. We followe
Autor:
C G, Brook
Publikováno v:
Archives of disease in childhood. 83(2)
Publikováno v:
Clinical endocrinology. 52(3)
Elevated blood pressure (BP) is an important predictor of morbidity and mortality from cardiovascular disease. Patients with Turner syndrome (TS) have a higher morbidity and mortality in middle age than the normal population. As BP in childhood or ea
Publikováno v:
Clinical endocrinology. 52(3)
Patients with Turner syndrome (TS) are at an increased risk of morbidity and mortality from cardiovascular disease. This study was undertaken to establish the prevalence of hypertension in patients with TS and to establish to what extent cardiovascul
Publikováno v:
Clinical endocrinology. 49(6)
Hypopituitarism, including severe GH deficiency, is an almost inevitable outcome of craniopharyngioma. However, some GH deficient children with this tumour may grow normally or even have accelerated growth postoperatively. To study this phenomenon we
Publikováno v:
Clinical endocrinology. 49(5)
We compared IGF-1 and IGFBP3 concentrations in a group of adults treated for brain tumours in childhood with those of matched controls, and investigated the relationship between the GH secretory pattern and IGF-1/IGFBP3 concentrations in the entire g
Publikováno v:
Clinical endocrinology. 49(1)
The endocrine manifestation of puberty, nocturnal pulsatile secretion of gonadotrophins precedes the physical manifestations by 2 years. Whether gonadal steroids and inhibin have a role to play in the regulation of pulsatile gonadotrophin release is
Autor:
C G, Brook
Publikováno v:
Acta paediatrica (Oslo, Norway : 1992). 87(5)